Regan John C 4

4 · FLUOR CORP · Filed Mar 2, 2026

AI-generated summary of this filing

Updated Mar 3, 2026

Fluor (FLR) CFO John Regan Exercises Options, Sells Shares

What Happened

John C. Regan, Chief Financial Officer of Fluor Corporation (FLR), exercised stock options to acquire 16,773 shares (exercise price $17.96, cost $301,243) on 2026-02-26 and then sold a total of 28,762 shares across 2026-02-26 and 2026-02-27 for aggregate proceeds of approximately $1,504,062.
The sales were reported as open-market transactions (S). One entry shows the derivative converted (M) at $0, reflecting the conversion of the options to common shares as part of the exercise.

Key Details

Transaction dates: 2026-02-26 (exercise + sale of 16,773 shares) and 2026-02-27 (sales of 8,094 and 3,895 shares).
Exercise: 16,773 shares at $17.96/share — total exercise cost $301,243.
Sales:
- 16,773 shares sold at a weighted avg $52.74 (total ~$884,591); prices ranged $52.37–$53.32 (F1).
- 8,094 shares sold at a weighted avg $51.41 (total ~$416,113); prices ranged $50.96–$51.93 (F2).
- 3,895 shares sold at a weighted avg $52.21 (total ~$203,358); prices ranged $52.01–$52.30 (F3).
Total shares sold: 28,762; total proceeds ≈ $1.50M.
Shares owned after the transactions: Not reported in the provided filing details.
Filing: Report filed 2026-03-02 for transactions dated 2026-02-26/27 — filed within the Form 4 two-business-day window (timely).
Footnote F4: The exercised options vested in three equal annual installments beginning March 6, 2022.

Context

This was effectively a cashless exercise: options were exercised and corresponding shares were converted and sold shortly thereafter (common when executives exercise and sell to cover exercise cost/taxes).
Sales by executives are routine and do not by themselves indicate company outlook; purchases generally carry more interpretive weight for investors.
The filing provides weighted-average sales prices and price ranges; the reporting person offered to supply the number of shares sold at each separate price on request (per footnotes).

Form 4

Period: 2026-02-26

CHIEF FINANCIAL OFFICER

Transactions

Exercise/Conversion
Common Stock
2026-02-26$17.96/sh+16,773$301,243→ 132,621 total
Sale
Common Stock
[F1]
2026-02-26$52.74/sh−16,773$884,591→ 115,848 total
Sale
Common Stock
[F2]
2026-02-27$51.41/sh−8,094$416,113→ 107,754 total
Sale
Common Stock
[F3]
2026-02-27$52.21/sh−3,895$203,358→ 103,859 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
[F4]
2026-02-26−16,773→ 0 total
Exercise: $17.96Exp: 2031-03-03→ Common Stock (16,773 underlying)

Footnotes (4)

[F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.37 to $53.32, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F2]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.96 to $51.93, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.01 to $52.30, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The options vested in three equal annual installments beginning on March 6, 2022.

Signature

/s/ Nicholas A. Gaspard by Power of Attorney|2026-03-02

1 file